Midi Health to supply testosterone therapy as demand from women spikes

Men have long turned to testosterone therapy to handle a wide range of issues as they age. But lately, women are increasingly doing the identical, seeing advantages from the hormone in addressing issues around libido, muscular health, energy and mood.

Midi Health, a virtual clinic focused on midlife health for girls, is now expanding access to testosterone hormone therapy after what it says has been a surge in demand across its greater than 200,000 patient network within the U.S.

While testosterone is traditionally related to men, it’s present in women, albeit at lower levels. Still, very similar to in men, the hormone plays a vital role and tends to say no with age.

Midi Health CEO Joanna Strober said while there may be research that backs women receiving testosterone therapy, “there’s just been loads of fear around it; unnecessary fear, as if you are going to turn right into a weightlifter, get huge muscles and your hair goes to fall out.”

Strober, a 2025 CNBC Changemaker, co-founded Midi Health in 2021 with a concentrate on helping women with midlife health issues like menopause and perimenopause, in addition to with longevity and aging well. That may often are available in the shape of hormonal therapy, and Strober said she views this push into testosterone therapy as one other extension of that, and one other solution to “give women options and see if it makes them feel good.”  

“Our job is to assist women optimize their health and provides them the tool chest to do this,” Strober said. “Hormones are a key component of that.”

So far, there aren’t any FDA-approved testosterone therapies for girls within the U.S., and Strober said that has led many ladies to try off-label or male-focused formulations. In other parts of the world, just like the U.K., it has been prescribed to women for a long time.

Midi Health is making a formulation specifically for girls, making it accessible through its clinicians and covered by major insurers. It’ll at first be available in 12 states, and the corporate plans a nationwide rollout as individual state regulations allow.

The corporate expects there to be demand. Roughly a yr ago, Midi Health issued fewer than 100 testosterone prescriptions per week as a part of a pilot program. Now, as discussions across the success of the treatment have grown on social media, there was nearly a tenfold increase in prescriptions.

Strober said like other treatment options offered to women by Midi Health, “it really does have to be personalized; it is not a one-shot fit all, so there’s an enormous opportunity to assist construct personalized health care solutions and provides it to people the best way they need to get health care.”

That approach has been key to Midi Health’s growth, and the corporate has reached a greater than $150 million revenue run rate and doubled its patient base this yr to greater than 20,000 per week, Strober said.

Like many firms in the ladies’s health industry, Midi Health was founded to assist women who were being underserved and neglected, with a particular concentrate on menopause and perimenopause care, something that affects lots of of tens of millions of girls a yr but historically has not seen the main target that other female health conditions have.

Midi Health just isn’t alone. Earlier this month, Hims & Hers Health launched a brand new specialty in women’s health that focuses on treatment plans for girls experiencing perimenopause and menopause. Fellow CNBC Changemaker Naomi Watts founded Stripes Beauty to concentrate on women’s health issues. Halle Berry, who has been vocal about her own challenges with perimenopause, founded a menopause-focused online care clinic, Respin Health. On top of that, the FDA held an authority panel on “Menopause and Hormone Alternative Therapy for Women” in July.

Strober said that in her view, “there may be room for loads of people on this space, because we’re talking about something that impacts each woman on this planet … this just isn’t a small area of interest.” She also noted that Midi Health’s care is roofed by insurance, unlike many other offerings.

As more women turn out to be aware that care is accessible, it provides Midi Health with an enormous opportunity, one which Strober said she believes puts the corporate on a path towards an eventual IPO. The corporate raised $50 million in a Series C round earlier this yr, has greater than $150 million in funding to date and has investors like Emerson Collective, Google Ventures and a set of female leaders that include comedian Amy Schumer, soccer star Brandi Chastain, and dressmaker Tory Burch.

“The thing we’re competing against is the shortage of women-oriented care, and I believe that’s just getting worse, mostly not higher,” Strober said. “We’re not a hormone company, we’re not a weight reduction company, we’re a women’s health-care company, and I believe women are increasingly on the lookout for women-focused healthcare, and that is the gap we’re filling.”